HealthEquity, Inc. (NASDAQ:HQY) Receives $110.57 Consensus Target Price from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received an average recommendation of “Moderate Buy” from the fourteen analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $110.5714.

Several equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Finally, Barrington Research reiterated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd.

HealthEquity Stock Performance

HQY opened at $85.21 on Friday. The company’s 50 day moving average is $84.91 and its 200-day moving average is $85.22. HealthEquity has a 1-year low of $72.76 and a 1-year high of $106.60. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.12 billion, a P/E ratio of 31.91, a PEG ratio of 1.43 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts predict that HealthEquity will post 3.92 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock worth $1,193,000 in the last ninety days. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Acumen Wealth Advisors LLC acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd lifted its position in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the period. Leonteq Securities AG lifted its position in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares during the period. Finally, Axiom Investment Management LLC acquired a new position in shares of HealthEquity in the 1st quarter worth approximately $33,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.